Department of Genetics, Washington University School of Medicine, St. Louis, MO.
McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO.
Clin Chem. 2021 Jan 30;67(2):415-424. doi: 10.1093/clinchem/hvaa267.
Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19 pandemic. Current gold-standard nucleic acid tests are hampered by supply shortages in critical reagents including nasal swabs, RNA extraction kits, personal protective equipment, instrumentation, and labor.
To overcome these challenges, we developed a rapid colorimetric assay using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) optimized on human saliva samples without an RNA purification step. We describe the optimization of saliva pretreatment protocols to enable analytically sensitive viral detection by RT-LAMP. We optimized the RT-LAMP reaction conditions and implemented high-throughput unbiased methods for assay interpretation. We tested whether saliva pretreatment could also enable viral detection by conventional reverse-transcription quantitative polymerase chain reaction (RT-qPCR). Finally, we validated these assays on clinical samples.
The optimized saliva pretreatment protocol enabled analytically sensitive extraction-free detection of SARS-CoV-2 from saliva by colorimetric RT-LAMP or RT-qPCR. In simulated samples, the optimized RT-LAMP assay had a limit of detection of 59 (95% confidence interval: 44-104) particle copies per reaction. We highlighted the flexibility of LAMP assay implementation using 3 readouts: naked-eye colorimetry, spectrophotometry, and real-time fluorescence. In a set of 30 clinical saliva samples, colorimetric RT-LAMP and RT-qPCR assays performed directly on pretreated saliva samples without RNA extraction had accuracies greater than 90%.
Rapid and extraction-free detection of SARS-CoV-2 from saliva by colorimetric RT-LAMP is a simple, sensitive, and cost-effective approach with broad potential to expand diagnostic testing for the virus causing COVID-19.
为了遏制持续的 COVID-19 大流行,需要快速、可靠且广泛的检测。当前的核酸检测金标准受到包括鼻腔拭子、RNA 提取试剂盒、个人防护设备、仪器和劳动力在内的关键试剂供应短缺的阻碍。
为了克服这些挑战,我们开发了一种使用逆转录环介导等温扩增(RT-LAMP)的快速比色测定法,该方法在没有 RNA 纯化步骤的情况下优化了人唾液样本。我们描述了唾液预处理方案的优化,以实现通过 RT-LAMP 进行分析敏感的病毒检测。我们优化了 RT-LAMP 反应条件,并实施了高通量无偏的测定解释方法。我们测试了唾液预处理是否也可以通过常规逆转录定量聚合酶链反应(RT-qPCR)来实现病毒检测。最后,我们在临床样本上验证了这些检测方法。
优化的唾液预处理方案通过比色 RT-LAMP 或 RT-qPCR 实现了从唾液中提取无病毒的 SARS-CoV-2 的分析敏感检测。在模拟样本中,优化的 RT-LAMP 检测方法的检测限为 59(95%置信区间:44-104)个粒子/反应。我们通过 3 种读数强调了 LAMP 检测方法的实施灵活性:肉眼比色法、分光光度法和实时荧光法。在一组 30 个临床唾液样本中,直接在未经 RNA 提取的预处理唾液样本上进行的比色 RT-LAMP 和 RT-qPCR 检测的准确率大于 90%。
通过比色 RT-LAMP 从唾液中快速且无需提取即可检测 SARS-CoV-2 是一种简单、敏感且具有成本效益的方法,具有广泛的潜力来扩大导致 COVID-19 的病毒的诊断检测。